Molluscum Contagiosum Clinical Presentation
- Author: Ashish C Bhatia, MD, FAAD; Chief Editor: Dirk M Elston, MD more...
History
Molluscum contagiosum is usually asymptomatic; however, individual lesions may be tender or pruritic. In general, the patient does not experience systemic symptoms, such as fever, nausea, or malaise.
The patient may recall contact with an infected sexual partner, family member, or other person. Patients who report having multiple sexual partners or unprotected sex have an increased risk of infection. Contact may be reported in children sharing a bath or in athletes sharing gymnasium equipment and benches. Parents may report recent exposure to other children affected with molluscum contagiosum at school, camp, or public recreational facilities (eg, gymnasiums, swimming pools).
If the patient has skin conditions that disrupt the epidermal layer, molluscum tends to spread more rapidly.
The patient may notice new lesions developing along a scratch in areas of involved skin. Patients with atopic dermatitis may have more extensive disease and may have a positive family history of atopy (eg, eczema, asthma, hayfever). Children frequently have active atopic dermatitis.
A report detailed an eruption of molluscum contagiosum in a patient who had undergone a renal transplant.[18] Case reports have detailed molluscum contagiosum eruptions in areas that were treated with tacrolimus 0.1% (Protopic).[5, 6, 7]
Duration of the individual lesion and of the attack varies. Although most cases resolve without therapy within 6-9 months, some persist for 3-4 years. Individual lesions seldom persist more than 2 months.
Patients with HIV or those receiving prednisone, methotrexate, or other immunosuppressive medications may have more extensive and resistant infections.
Patients infected with HIV
Patients generally have a low CD4 count, with the severity of infection being inversely related to the count.
Patients who are poorly compliant or noncompliant with highly active antiretroviral therapy (HAART) for the treatment of HIV are at an increased risk, as are patients who have multiple sexual partners. The frequency of unprotected sex also increases the risk of transmission.
Physical Examination
Lesions are discrete, nontender, flesh-colored, dome-shaped papules that show a central umbilication (which is more apparent when the lesion is frosted with liquid nitrogen). (See the image below.)
Presented here are the classic umbilicated papules of molluscum contagiosum lesions on the cheek of a child. Facial lesions occur frequently in children, although lesions generally are few. Lesions are usually 2-5 mm (rarely up to 1.5 cm in the case of giant molluscus) in diameter and may be present in groups or widely disseminated. Immunocompetent children and adults usually have fewer than 20 lesions. Larger lesions may have several distinct clumps of molluscum bodies (see the image below). Beneath the umbilicated center is a white, curdlike core that contains molluscum bodies. Some lesions become confluent to form a plaque (agminate form).
Larger lesions may have several clumps of molluscum bodies rather than the more common single central umbilication. This may make them difficult to recognize as molluscum contagiosum. Lesions may be located anywhere; however, a predilection for the face, trunk, and extremities is observed in children and a predilection for the groin and genitalia is observed in adults. Lesions are seldom found on the palms and are rarely documented on the soles, oral mucosa, or conjunctiva.
Distribution is influenced by the mode of infection, type of clothing worn, and climate. In sexually active individuals, the lesions may be confined to the penis, pubis, and inner thighs (see the image below). Widespread and persistent molluscum contagiosum may occur in patients with AIDS and may be the presenting complaint.
Molluscum contagiosum on the shaft of the penis. Molluscum contagiosum in the genital region of adults is most commonly acquired as a sexually transmitted disease. Molluscum contagiosum may be randomly associated with other lesions, such as epidermal cysts, nevocellular nevi, sebaceous hyperplasias, and Kaposi sarcoma. Pseudocystic molluscum contagiosum, giant molluscum contagiosum, and molluscum contagiosum associated with other lesions are responsible for frequent clinical misdiagnosis.
Other characteristics of molluscum contagiosum to consider include the following:
- Intertriginous areas - Hundreds of lesions may develop in intertriginous areas, such as the axillae and intercrural region
- Atopic dermatitis - Patients with atopic dermatitis occasionally develop large numbers of lesions, which are confined to areas of lichenified skin
- Eczema - Approximately 10% of patients develop eczema around the lesions, with this being attributed to toxic substances produced by the virus or to a hypersensitivity reaction to the virus; eczema that is associated with molluscum lesions subsides spontaneously following removal (see the first image below)
- Inflammatory changes - These result in suppuration, crusting, and eventual resolution of the lesion; this inflammatory stage does not usually represent secondary infection and seldom requires antibiotic therapy (see the second image below)
Approximately 10% of patients develop eczema around lesions. Eczema associated with molluscum lesions spontaneously subsides following removal.
After trauma, or spontaneously after several months, inflammatory changes result in suppuration, crusting and eventual resolution of the lesion. This inflammatory stage does not usually represent secondary infection and seldom requires antibiotic therapy.
Disfiguring lesions may occur in patients with the following conditions:
- AIDS - Facial and perioral molluscum contagiosum are most commonly observed as a manifestation of HIV infection, particularly in homosexual men with HIV[19] ; at the time of molluscum contagiosum diagnosis, the CD4 count is low
- Immunocompromise - Lesions are especially common and extensive on the face and neck
- Lymphocytic leukemia
- Congenital immunodeficiency
- Selective immunoglobulin M (IgM) deficiency
- Thymoma
- Treatment with prednisone and methotrexate
- Disseminated malignancy
- Refractory atopic dermatitis
Scholz J, Rosen-Wolff A, Bugert J, et al. Epidemiology of molluscum contagiosum using genetic analysis of the viral DNA. J Med Virol. Feb 1989;27(2):87-90. [Medline].
Freeman CL, Moriarty AT. Molluscum contagiosum presenting as cellulitis in an AIDS patient: cytologic and ultrastructural features. Diagn Cytopathol. Jun 1995;12(4):345-9. [Medline].
Choong KY, Roberts LJ. Molluscum contagiosum, swimming and bathing: a clinical analysis. Australas J Dermatol. May 1999;40(2):89-92. [Medline].
Connell CO, Oranje A, Van Gysel D, Silverberg NB. Congenital molluscum contagiosum: report of four cases and review of the literature. Pediatr Dermatol. Sep-Oct 2008;25(5):553-6. [Medline].
Ahn BK, Kim BD, Lee SJ, Lee SH. Molluscum contagiosum infection during the treatment of vitiligo with tacrolimus ointment. J Am Acad Dermatol. Mar 2005;52(3 Pt 1):532-3. [Medline].
Fery-Blanco C, Pelletier F, Humbert P, Aubin F. [Disseminated molluscum contagiosum during topical treatment of atopic dermatitis with tacrolimus: efficacy of cidofovir]. Ann Dermatol Venereol. May 2007;134(5 Pt 1):457-9. [Medline].
Wilson LM, Reid CM. Molluscum contagiosum in atopic dermatitis treated with 0.1% tacrolimus ointment. Australas J Dermatol. Aug 2004;45(3):184-5. [Medline].
Senkevich TG, Koonin EV, Bugert JJ, et al. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology. Jun 23 1997;233(1):19-42. [Medline].
Mahe A, Prual A, Konate M, Bobin P. Skin diseases of children in Mali: a public health problem. Trans R Soc Trop Med Hyg. Sep-Oct 1995;89(5):467-70. [Medline].
Konya J, Thompson CH. Molluscum contagiosum virus: antibody responses in persons with clinical lesions and seroepidemiology in a representative Australian population. J Infect Dis. Mar 1999;179(3):701-4. [Medline].
Becker TM, Blount JH, Douglas J, Judson FN. Trends in molluscum contagiosum in the United States, 1966-1983. Sex Transm Dis. Apr-Jun 1986;13(2):88-92. [Medline].
Reynolds MG, Holman RC, Yorita Christensen KL, Cheek JE, Damon IK. The Incidence of Molluscum contagiosum among American Indians and Alaska Natives. PLoS One. 2009;4(4):e5255. [Medline]. [Full Text].
Laxmisha C, Thappa DM, Jaisankar TJ. Clinical profile of molluscum contagiosum in children versus adults. Dermatol Online J. Dec 2003;9(5):1. [Medline]. [Full Text].
Dohil MA, Lin P, Lee J, Lucky AW, Paller AS, Eichenfield LF. The epidemiology of molluscum contagiosum in children. J Am Acad Dermatol. Jan 2006;54(1):47-54. [Medline].
Smolinski KN, Yan AC. How and when to treat molluscum contagiosum and warts in children. Pediatr Ann. Mar 2005;34(3):211-21. [Medline].
[Guideline] Clinical Effectiveness Group. National guideline for the management of molluscum contagiosum. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex Transm Infect. Aug 1999;75 Suppl 1:S80-1. [Medline].
Braue A, Ross G, Varigos G, Kelly H. Epidemiology and impact of childhood molluscum contagiosum: a case series and critical review of the literature. Pediatr Dermatol. Jul-Aug 2005;22(4):287-94. [Medline].
Mansur AT, Göktay F, Gündüz S, Serdar ZA. Multiple giant molluscum contagiosum in a renal transplant recipient. Transpl Infect Dis. Sep 2004;6(3):120-3. [Medline].
Betlloch I, Pinazo I, Mestre F, et al. Molluscum contagiosum in human immunodeficiency virus infection: response to zidovudine. Int J Dermatol. Jun 1989;28(5):351-2. [Medline].
Hornor G. Ano-genital warts in children: Sexual abuse or not?. J Pediatr Health Care. Jul-Aug 2004;18(4):165-70. [Medline].
Nageswaran A, Kinghorn GR. Sexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosum. Genitourin Med. Aug 1993;69(4):303-11. [Medline].
Munoz-Perez MA, Colmenero MA, Rodriguez-Pichardo A, et al. Disseminated cryptococcosis presenting as molluscum-like lesions as the first manifestation of AIDS. Int J Dermatol. Sep 1996;35(9):646-8. [Medline].
Buller RM, Burnett J, Chen W, Kreider J. Replication of molluscum contagiosum virus. Virology. Nov 10 1995;213(2):655-9. [Medline].
Cribier B, Scrivener Y, Grosshans E. Molluscum contagiosum: histologic patterns and associated lesions. A study of 578 cases. Am J Dermatopathol. Apr 2001;23(2):99-103. [Medline].
Hanna D, Hatami A, Powell J, et al. A prospective randomized trial comparing the efficacy and adverse effects of four recognized treatments of molluscum contagiosum in children. Pediatr Dermatol. Nov-Dec 2006;23(6):574-9. [Medline].
Buckley R, Smith K. Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease. Arch Dermatol. Oct 1999;135(10):1167-9. [Medline].
Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. Aug 2004;74(2):134-8, 141-2. [Medline].
Ross GL, Orchard DC. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients. Australas J Dermatol. May 2004;45(2):100-2. [Medline].
Syed TA, Lundin S, Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology. 1994;189(1):65-8. [Medline].
Watanabe T, Tamaki K. Cidofovir diphosphate inhibits molluscum contagiosum virus DNA polymerase activity. J Invest Dermatol. May 2008;128(5):1327-9. [Medline].
Ordoukhanian E, Lane AT. Warts and molluscum contagiosum: beware of treatments worse than the disease. Postgrad Med. Feb 1997;101(2):223-6, 229-32, 235. [Medline].
Takematsu H, Tagami H. Proinflammatory properties of molluscum bodies. Arch Dermatol Res. 1994;287(1):102-6. [Medline].
Romiti R, Ribeiro AP, Grinblat BM, et al. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol. May-Jun 1999;16(3):228-31. [Medline].
Romiti R, Ribeiro AP, Romiti N. Evaluation of the effectiveness of 5% potassium hydroxide for the treatment of molluscum contagiosum. Pediatr Dermatol. Nov-Dec 2000;17(6):495. [Medline].
Mathes EF, Frieden IJ. Treatment of molluscum contagiosum with cantharidin: a practical approach. Pediatr Ann. Mar 2010;39(3):124-8, 130. [Medline].
Niizeki K, Hashimoto K. Treatment of molluscum contagiosum with silver nitrate paste. Pediatr Dermatol. Sep-Oct 1999;16(5):395-7. [Medline].
Silverberg NB, Sidbury R, Mancini AJ. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients. J Am Acad Dermatol. Sep 2000;43(3):503-7. [Medline].
Cathcart S, Coloe J, Morrell DS. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection. Clin Pediatr (Phila). Mar 2009;48(2):161-5. [Medline].
Epstein E. Cantharidin treatment of molluscum contagiosum. Acta Derm Venereol. 1989;69(1):91-2. [Medline].
Martin-Garcia RF, Garcia ME, Rosado A. Modified curettage technique for molluscum contagiosum. Pediatr Dermatol. Mar-Apr 2007;24(2):192-4. [Medline].
Simonart T, De Maertelaer V. Curettage treatment for molluscum contagiosum: a follow-up survey study. Br J Dermatol. Nov 2008;159(5):1144-7. [Medline].
Squeezing causes less scarring than phenol ablation in molluscum contagiosum. BMJ. Dec 11 1999;319(7224):E. [Medline].
Weller R, O'Callaghan CJ, MacSween RM, White MI. Scarring in Molluscum contagiosum: comparison of physical expression and phenol ablation. BMJ. Dec 11 1999;319(7224):1540. [Medline].
Lindau MS, Munar MY. Use of duct tape occlusion in the treatment of recurrent molluscum contagiosum. Pediatr Dermatol. Sep-Oct 2004;21(5):609. [Medline].
Binder B, Weger W, Komericki P, Kopera D. Treatment of molluscum contagiosum with a pulsed dye laser: Pilot study with 19 children. J Dtsch Dermatol Ges. Feb 2008;6(2):121-5. [Medline].
Chatproedprai S, Suwannakarn K, Wananukul S, Theamboonlers A, Poovorawan Y. Efficacy of pulsed dyed laser (585 nm) in the treatment of molluscum contagiosum subtype 1. Southeast Asian J Trop Med Public Health. Sep 2007;38(5):849-54. [Medline].
Hammes S, Greve B, Raulin C. [Molluscum contagiosum: treatment with pulsed dye laser]. Hautarzt. Jan 2001;52(1):38-42. [Medline].
Hughes PS. Treatment of molluscum contagiosum with the 585-nm pulsed dye laser. Dermatol Surg. Feb 1998;24(2):229-30. [Medline].
Michel JL. Treatment of molluscum contagiosum with 585 nm collagen remodeling pulsed dye laser. Eur J Dermatol. Mar-Apr 2004;14(2):103-6. [Medline].
Nelson MR, Chard S, Barton SE. Intralesional interferon for the treatment of recalcitrant molluscum contagiosum in HIV antibody positive individuals--a preliminary report. Int J STD AIDS. Sep-Oct 1995;6(5):351-2. [Medline].
Inui S, Asada H, Yoshikawa K. Successful treatment of molluscum contagiosum in the immunosuppressed adult with topical injection of streptococcal preparation OK-432. J Dermatol. Sep 1996;23(9):628-30. [Medline].
Metkar A, Pande S, Khopkar U. An open, nonrandomized, comparative study of imiquimod 5% cream versus 10% potassium hydroxide solution in the treatment of molluscum contagiosum. Indian J Dermatol Venereol Leprol. Nov-Dec 2008;74(6):614-8. [Medline].
Skinner RB Jr, Ray S, Talanin NY. Treatment of molluscum contagiosum with topical 5% imiquimod cream. Pediatr Dermatol. Sep-Oct 2000;17(5):420. [Medline].
Barba AR, Kapoor S, Berman B. An open label safety study of topical imiquimod 5% cream in the treatment of molluscum contagiosum in children. Dermatol Online J. Feb 2001;7(1):20. [Medline].
Hengge UR, Esser S, Schultewolter T. Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol. Nov 2000;143(5):1026-31. [Medline].
Maronn M, Salm C, Lyon V, Galbraith S. One-year experience with candida antigen immunotherapy for warts and molluscum. Pediatr Dermatol. Mar-Apr 2008;25(2):189-92. [Medline].
Lacarrubba F, Nasca MR, Micali G. Advances in the use of topical imiquimod to treat dermatologic disorders. Ther Clin Risk Manag. Feb 2008;4(1):87-97. [Medline]. [Full Text].
Myhre PE, Levy ML, Eichenfield LF, Kolb VB, Fielder SL, Meng TC. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of molluscum contagiosum in children. Pediatr Dermatol. Jan-Feb 2008;25(1):88-95. [Medline].
Bayerl C, Feller G, Goerdt S. Experience in treating molluscum contagiosum in children with imiquimod 5% cream. Br J Dermatol. Nov 2003;149 Suppl 66:25-9. [Medline].
Brown CW Jr, O'Donoghue M, Moore J, Tharp M. Recalcitrant molluscum contagiosum in an HIV-afflicted male treated successfully with topical imiquimod. Cutis. Jun 2000;65(6):363-6. [Medline].
Veregen (sinecatechins) Ointment, 15% [package insert]. Planegg/Martinsried, Germany: MediGene AG; 2011.
Toro JR, Wood LV, Patel NK. Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1. Arch Dermatol. Aug 2000;136(8):983-5. [Medline].
Zabawski EJ Jr, Cockerell CJ. Topical cidofovir for molluscum contagiosum in children. Pediatr Dermatol. Sep-Oct 1999;16(5):414-5. [Medline].
[Best Evidence] van der Wouden JC, van der Sande R, van Suijlekom-Smit LW, Berger M, Butler C, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. Oct 7 2009;CD004767. [Medline].
Burke BE, Baillie JE, Olson RD. Essential oil of Australian lemon myrtle (Backhousia citriodora) in the treatment of molluscum contagiosum in children. Biomed Pharmacother. May 2004;58(4):245-7. [Medline].

